Ozempic Too Expensive? 5 Ways to Get Semaglutide for Under $100/Month

1Compounded Semaglutide Through a Telehealth Provider

Compounded semaglutide is the single most accessible path to semaglutide for under $100/month. It is the identical active molecule — a GLP-1 receptor agonist — prepared by licensed compounding pharmacies instead of Novo Nordisk. Because compounding pharmacies do not carry Novo Nordisk's overhead, patent premium, or marketing costs, the same drug can be priced 90% lower.

Through Trimi, compounded semaglutide starts at $99/month. The process: complete an online health assessment, get evaluated by a board-certified provider within 24 hours, and receive your medication by mail in 5–7 business days. No insurance, no prior authorization, no wait.

• No income documentation required
• Available to any patient who qualifies clinically
• Prescription required — handled through Trimi's online provider evaluation
• Ships from FDA-registered, PCAB-accredited compounding pharmacies
• Third-party batch testing for potency and sterility

See full details: is $99 semaglutide real?

2Novo Nordisk NovoCare Patient Assistance Program

Novo Nordisk's NovoCare program provides free or reduced-cost Ozempic and Wegovy to uninsured or underinsured patients who meet income eligibility criteria. If you qualify, you receive brand-name medication at no or very low cost. The trade-off is an application process involving income documentation and approval timelines of several weeks.

• Requires income documentation (typically below 400% of federal poverty line)
• Must be uninsured or underinsured
• Application reviewed by Novo Nordisk — takes 2–4 weeks
• Provides brand-name Ozempic or Wegovy, not compounded
• Check NovoCare.com directly for current eligibility terms — they change

3Insurance Coverage — After a Successful Prior Authorization

If your plan covers Ozempic or Wegovy and your prior authorization is approved, your out-of-pocket cost may be a $0–$150 copay. This is the lowest long-term cost option when insurance is working — but the "if" is substantial. Many plans have obesity-drug exclusions, PA denial rates are high, and the appeal process can take months.

If your PA was denied, see our detailed guide: prior authorization denied for GLP-1 — your options.

4340B Pricing at Qualifying Healthcare Facilities

The 340B Drug Pricing Program requires pharmaceutical manufacturers to provide significant discounts to qualifying healthcare facilities — typically federally qualified health centers (FQHCs), safety-net hospitals, and certain community clinics. If you receive care at a 340B-eligible facility, you may access brand-name GLP-1 medications at dramatically reduced prices.

This option is geographically and institutionally limited — you need to both live near a qualifying facility and receive your obesity care there. Call local FQHCs or community health centers to ask about GLP-1 availability and 340B pricing.

5Novo Nordisk Savings Cards (For Commercially Insured Patients)

Novo Nordisk offers copay savings cards for Ozempic and Wegovy that reduce out-of-pocket costs for commercially insured patients to as low as $0–$25 per month. These are distinct from patient assistance — they are copay reduction programs that work on top of insurance billing.

Important limitations: savings cards do not work for Medicare or Medicaid patients (this is a federal anti-kickback compliance requirement), and they are voided if your insurance denies coverage. They only reduce the copay amount on an approved, covered prescription.